Indoco Remedies Ltd., a research focused pharmaceutical company, has received final approval from the US Food and drug Administration
Zydus Lifesciences is developing a new semaglutide formulation for diabetes and obesity, two rapidly growing chronic conditions that are becoming increasingly debilitating. Rather than requiring patients to...
Dr. Hemant G. Koshia, Commissioner of the Food and Drug Control Administration (FDCA) stated that the Gujarat government is in the final stage of approving a high-tech drug testing laboratory in Surat.
A panel of advisers to the U.S. Food and Drug Administration (FDA) unanimously recommended that COVID-19 vaccines for the 2025–26 season target updated strains of the JN.1 variant, and particularly...
Researchers at the National Institutes of Health (NIH) have identified distinct patterns of blood and urine metabolites that can objectively measure a person’s intake of ultra-processed foods. Published...
Bayer has initiated a Phase I clinical trial for BAY 3670549, a first-in-class, highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, targeting atrial fibrillation (AFib)...
According to Anish Bafna, CEO and Managing Director of Healthium Medtech, sustainability is growing a vital factor in global healthcare finding, especially across the US and Europe.
-min.png)
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has advised its members to freshly apply again to the Production Linked Incentive.
Bharat Biotech International Ltd announced that it successfully completed Phase III clinical trials for its oral cholera vaccine, Hillchol. The double-blind, randomized study evaluated Hillchol for safety, immunogenicity, and consistency, and...
Cipla has launched ZEMDRI (Plazomicin) in India as a brand-new intravenous antibiotic for use against complicated urinary tract infections (cUTI) such as pyelonephritis. Since 150 million people globally and rising antimicrobial resistance are huge c
, CDSCO.jpg)
